Manage Your Liver
Q:

Founder of Kyotsujigyo honoured to be University Professor

Founder of Kyotsujigyo honoured to be University Professor
A:

Our founder Prof Sha has completed his Ph.D. on Health maintenance last year. And was honoured to be invited as Professor at the Musashino Gakuin University, Japan on International Communication.

 

His main focus as Professor is on Health Maintenance and disease prevention culture, Japanese Kampo, and dementia.

 

Profile

1953 - Born in Shanghai 

1981 - Graduated from Shanghai Normal University

1887 - Moved to Japan

1991 - Established Kyotsujigyo Inc.

1997 - Acquired Japanese Nationality

2015 - Complete Ph.D. on International communication   

            - Thesis: A Study on Analysis of Yojokun‐Influence from Chinese Classic Texts

2016 - Became as a Professor at the Musashino Gakuin University, Japan 

             - Health Maintenance and disease prevention.

 

Research and Patent Achievement

As a result of longstanding research based on traditional oriental medicine, he successfully formulated Yojo supplements designed to maintain and recover liver and kidney functions, anti-cancer, fatigue recovery, exercise capacity enhancement, energy enhancement, reduce medication side effects, prevent and minimise the symptoms of cold and influenza etc. 

 

Above effects have been proven through scientific researches, with these significant evidence of benefits, his products acquired 7 patents in the US, Europe, Canada, China and Japan. 

 

US        NO.6586017

     NO.6280776

     NO.7205010

Canada NO.2291974

Europe  NO.1002540

China    NO.ZL03107003.5

Japan    NO.4588132

 

Research and Academic Exchange

1999~2013    

Over 40 conferences and exchanges at Japan & oversea hepatology society and Cancer society. 

 

2002~2005

The research paper on efficacy against liver cirrhosis and NASH received two excellent awards winning at the Japan Society of Hepatology.

 

2006~2013

Published 11 times on world famous academic journals include 「Annals of New York Academy of Science.

 

2006~2013

14 pieces of research paper and results have been listing on National Medical Library (Pubmed), shared to professionals and opened to public.

 

Conferencece presentation

2013

The 16th The Japanese society for complementary and alternative medicine 

“The Search for Yo-jyo supplement possibility in hepatitis prevention and liver damage”

 

Publication

  • The amazing power of Panax and Eucommia.
  • The real health preservation of oriental medicine. 
  • Buy the finest quality herbs in Japan. 
  • No more liver cancer from Hep C.
  • Boost up your liver!
Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Prof ShaKyotsujigyoYHKMusashino Gakuin University
Related Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us